We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Clues to Cause of Stomach Cancer

By Biotechdaily staff writers
Posted on 24 Sep 2002
Researchers have found that mutations on a receptor molecule called gp130 in mice resulted in symptoms that mirrored those of gastric cancer and large bowel inflammation in humans, suggesting targets for drugs to treat these conditions. More...
The research was reported in the October 2002 issue of Nature Medicine.

The gp130 molecule is found on the surface of cells and is traditionally involved in helping to regulate the body's immune system. The molecule serves as a molecular antenna, transmitting instructions from cytokines to individual cells, telling them how to respond to their environment. The researchers were surprised when mice carrying the mutations in gp130 developed cellular changes similar to those of gastric cancer.

"Nobody suspected that interference with the messenger service engaged by gp130 could be linked with a 100% prevalence of early stages of gastric cancer in mice,” said Andy Giraud, associate professor at the University of Melbourne (Australia) and a member of the research team.

On set of mice had a single amino acid change to the gp130 molecule, which induced the changes reminiscent of early gastric cancer. A second set of mice has a small chunk chopped off the end of the molecule. This set showed reduced ability to repair damage in the colon and rectum, making them susceptible to intestinal injury resulting in large bowel inflammation.

"What has been designed as a regenerative mechanism gets out of control in the stomach with one mutation, while not being activated in the large bowel as a result of the other mutation. What we have yet to find is the cancer spreading to other organs, which is what eventually kills patients,” said Dr. Matthias Ernst, of the Ludwig Institute for Cancer Research in Melbourne, also a member of the research team.




Related Links:
University of Melbourne

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Rapid Sepsis Test
SeptiCyte RAPID
New
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.